Iron Chelators has 3 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Exagamglogene Autotemcel, Lovotibeglogene Autotemcel, Marnetegragene Autotemcel. Patients taking Iron Chelators should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 3
Major (3)
- Iron Chelators + Exagamglogene Autotemcel— Discontinue at least 7 days prior to myeloablative conditioning. Avoid non-myelosuppressive iron chelators for 3 months …
- Iron Chelators + Lovotibeglogene Autotemcel— Drug-drug interactions must be considered with mobilization and myeloablative conditioning. Discontinue at least 7 days …
- Iron Chelators + Marnetegragene Autotemcel— Discontinue at least 7 days prior to myeloablative conditioning initiation. Avoid myelosuppressive iron chelators for 6 …